Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Restructuring Costs: 2020-2025

Historic Restructuring Costs for Lifecore Biomedical (LFCR) over the last 6 years, with May 2025 value amounting to -$1.7 million.

  • Lifecore Biomedical's Restructuring Costs fell 114.92% to -$115,000 in Q1 2025 from the same period last year, while for Feb 2025 it was $1.6 million, marking a year-over-year increase of 67.49%. This contributed to the annual value of -$1.7 million for FY2025, which is 205.50% down from last year.
  • Per Lifecore Biomedical's latest filing, its Restructuring Costs stood at -$1.7 million for FY2025, which was down 205.50% from $1.7 million recorded in FY2024.
  • Lifecore Biomedical's Restructuring Costs' 5-year high stood at $13.4 million during FY2021, with a 5-year trough of -$1.7 million in FY2025.
  • Its 3-year average for Restructuring Costs is $1.4 million, with a median of $1.7 million in 2024.
  • Its Restructuring Costs has fluctuated over the past 5 years, first soared by 229.43% in 2021, then slumped by 205.50% in 2025.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Restructuring Costs stood at $13.4 million in 2021, then crashed by 37.41% to $8.4 million in 2022, then plummeted by 49.95% to $4.2 million in 2023, then tumbled by 60.42% to $1.7 million in 2024, then tumbled by 205.50% to -$1.7 million in 2025.